Karaciğer Fibrozisinin İnvazif Olmayan Dolaylı Biyokimyasal Belirteçleri

Kayadibi, Hüseyin; Sertoğlu, Erdim

doi:10.17827/aktd.51029

Cited by 1 publication

(1 citation statement)

References 67 publications

(58 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Despite the original study that found an AUROC of 0.88 for fibrosis and 0.94 for cirrhosis [19], some of the subsequent studies failed to reach such high values or showed that several other markers were superior to APRI [20]. However, there is considerable amount of evidence that APRI can successfully be used for the assessment of liver fibrosis in patients with chronic hepatitis C infection [21]. In our results, APRI has not got high AUROC values for discriminating patients with and without significant and severe fibrosis, and cirrhosis.…”

Section: Discussionmentioning

confidence: 99%

The age, bilirubin and albumin (ABA) index: a novel noninvasive index for predicting liver fibrosis in patients with chronic hepatitis C infection

Yılmaz

Kayadibi

Yeniova

et al. 2021

European Journal of Gastroenterology &Amp; Hepatology

View full text Add to dashboard Cite

Aim It was to assess the diagnostic performance characteristics of a novel index, (ABA), which utilizes age, bilirubin and albumin to predict significant and severe fibrosis, and cirrhosis in patients with chronic hepatitis C infection. Methods A total of 114 patients were included in this study. The liver biopsies were graded using the Ishak scoring system. Diagnostic performance of the ABA index was compared to aspartate aminotransferase (AST) to alanine aminotransferase ratio, age platelet index, AST to platelet ratio index, γ-glutamyl transpeptidase (GGT) to platelet ratio index, FIB-4, FibroQ, Goteborg University Cirrhosis Index, King’s score, GGT/international normalization ratio, platelet to lymphocyte ratio, neutrophil to lymphocyte ratio, white blood cell to platelet distribution width ratio and mean platelet volume to platelet distribution width ratio (MPV/PDW) by receiver operating characteristics (ROC) curve analysis. Results The ABA index was formulated as 1.5 + (0.065 × age) + (1.85 × bilirubin) − (1.65 × albumin) according to the multivariate logistic regression analysis. According to the ROC curve analyses, the ABA index had the area under these ROC curves (AUROCs) of 0.805 [95% confidence interval (CI), 0.727–0.883] for significant fibrosis, 0.874 (95% CI, 0.804–0.943) for severe fibrosis and 0.895 (95% CI, 0.828–0.961) for cirrhosis. Conclusion The ABA index was found to be superior to other evaluated noninvasive indexes of liver fibrosis by use of the cutoff point of 0 and 1. These findings should be confirmed by prospective and multicenter studies in patients with chronic hepatitis C infection.

show abstract

Section: Discussionmentioning

confidence: 99%